Læknablaðið - 15.07.1998, Blaðsíða 28

550
LÆKNABLAÐIÐ 1998; 84
efri og neðri hluta þvagfæra er metin.
Að lokum er óhætt að benda á að reglubund-
ið eftirlit og fækkun fylgikvilla hefur ekki að-
eins í för með sér ávinning fyrir sjúklinginn
sjálfan heldur einnig þjóðfélagslegan og fjár-
hagslegan ávinning. A norrænu þingi um
mænuskaða, sem haldið var í Reykjavík í sept-
ember á síðastliðnu ári, kom fram í erindi W S
Masry, gestafyrirlesara frá Bretlandi, að allt að
sex sinnum ódýrara er að koma í veg fyrir
fylgikvillana með forvörnum í stað þess að
meðhöndla þá eftir að þeir koma upp.
Þakkir:
Eftirtaldir aðilar hafa komið með einum eða
öðrum hætti að framkvæmd þessarar rannsókn-
ar og fá kærar þakkir fyrir veitta aðstoð: Alma
Harðardóttir hjúkrunarfræðingur þvagfæra-
skurðdeild Sjúkrahúss Reykjavíkur; Guðný
Daníelsdóttir læknir endurhæfingardeild
Sjúkrahúss Reykjavíkur; læknar röntgendeildar
Sjúkrahúss Reykjavíkur; Sigrún Knútsdóttir
sjúkraþjálfari endurhæfingardeild Sjúkrahúss
Reykjavíkur; Ragnar Oskarsson, Samtök end-
urhæfðra mænuskaðaðra og Vísindasjóður
Sjúkrahúss Reykjavíkur.
HEIMILDIR
1. Wyndaele JJ. Neurourology in SCI patients. Paraplegia
1992; 30: 50-3.
2. Walsh J. Cost of SCI in Australia. Paraplegia 1988; 26:
380-8.
3. Anonymous. American Spinal Injury Association 1992:
Standards for Neurological and Functional Classification
of SCI. ASIA.
4. Finocchiaro DN, Herzfeld ST. Understanding Autonomic
Dysreflexia. Am J Nurs 1990; 90: 56-9.
5. Blaivas JG, Sinha HP, Zayed AH, Labib KB. Detrusor-
external sphincter dyssynergia. J Urol 1981; 125: 542-4.
6. Light JK, Beric A. Detrusor function in suprasacral SCI. J
Urol 1992; 148: 355-8.
7. Bracken MB, Shepard MJ, Collins WF, Holford TR,
Young W, Baskin DS, et al. A randomised controlled trial
of methylprednisolon or naloxone in the treatment of
acute SCI. N Engl J Med 1990; 332: 1405-11.
8. Knútsdóttir S. SCI in Iceland. A follow up study. Para-
plegia 1993; 31: 68-72.
9. Biering-Sorensen E, Pedersen V, Clausen S. Epidemiology
of spinal cord lesion in Denmark. Paraplegia 1990; 28:
105-18.
10. Shingu H, Ohama M, Ikata T, Katoh S, Akatsu T. A nation-
wide epidemiological survey of SCI in Japan from January
1990 to December 1992. Paraplegia 1995; 33: 183-6.
11. Woodruff BA, Baron RC. A description of nonfatal spinal
cord injury using a hospital-based registry. Am J Prev Med
1994; 10: 10-4.
12. Selzman AA, Hampel N. Urological complications of SCI.
Urologic clinics of North America 1993; 20: 451-64.
13. Abramson AS. Neurogenic bladder: a guide to evaluation
and management. Arch Phys Med Rehabil 1983; 64: 6-10.
14. Rulkowsky SB. Middleton JW, Truman G. Hagen DL,
Tyan JP. The influence of bladder management on fertility
in spinal cord injured males. Paraplegia 1995; 33: 263-6.
15. Chai T, Chung AK, Belville WD. Faerber GJ. Compliance
and complications of clean intermittent calheterization in
the spinal cord injured patient. Paraplegia 1995; 33: 161-
3.
16. Hill VB, Davies WE. A swing to intermittent clean self
calheterisation as a preferred mode of management of the
neuropathic bladder for the dextrous spinal cord patient.
Paraplegia 1988; 26: 405-12.
17. Gardner BP, Parsons KF, Machin DG, Galloway A,
Krishnan KR. The urological management of spinal cord
damaged patients: a clinical algorithm. Paraplegia 1988;
24: 138-47.
18. Stover SL, Lloyd K, Walters K, Jackson AB. Urinary tract
infection in spinal cord injury. Arch Phys Med Rehabil
1989; 70: 47-54.
19. Waites KB. Canupp KC, DeVivo MJ. Epidemiology and
risk factors for urinary tract infection following spinal
cord injury. Arch Phys Med Rehabil 1993; 74: 691-5.
20. De Vivo MJ, Fine PR, Cutter GR, Maetz HM. The risk of
renal calculi in spinal cord injury patients. J Urol 1984;
131: 857-60.
21. Stonehil! WH, Dmochowski RR, Patterson AL, Cox CE.
Risk factors for bladder tumors in SCI patients. J Urol
1996; 155: 1248-50.
22. Salzberg CA, Byrne DW, Cayten CG. van Niewerburgh P.
Murphy JG, Viehbeck M. A new pressure ulcer risk
assessment scale for individuals with spinal cord injury.
Am J Phys Med Rehabil 1996; 75: 96-104.
23. Byrne DW. Salzberg CA. Major risk factors for pressure
ulcers in the spinal cord disabled: a literature review.
Spinal Cord 1996; 34: 255-63.
24. Herzog JA. Deep vein thrombosis in the rehabilitation
client. Rehab Nursing 1992; 17: 196-8.
25. DeVivo MJ. Kartus PL. Stover SL, Rutt RD, Fine PR.
Cause of death for paticnts with spinal cord injuries. Arch
Intem Med 1989; 149: 1761-6.
26. Merli GJ. Crabbe S, Paluzzi RG, Fritz D. Etiology,
incidence, and prevention of deep vein thrombosis in
acute spinal cord injury. Arch Phys Med Rehabil 1993; 74:
1199-205.
27. Reines HD, Harris RC. Pulmonary complications of acute
spinal cord injuries. Neurosurgery 1987; 21: 193-6.
28. Merli GJ, Herbison GJ, Ditunno JF, Weitz HH, Henzes JH,
Park CH,
et al. Deep vein thrombosis: prophylaxis in acute spinal cord
injured patient. Arch Phys Med Rehabil 1988; 69: 661-4.
29. Fujii Y, Mammen EF. Farag A, Muz J, Salciccioli GG,
Weingarden ST. Thrombosis in spinal cord injury. Thromb
Res 1992; 68: 357-68.
30. Waring WP, Karunas RS. Acute spinal cord injuries and
the incidence of clinically occurring thromboembolic
disease. Paraplegia 1991; 29: 8-16.
31. Fishburn MJ, Marino RJ. Ditunno JF Jr. Atelectasis and
pneumonia in acute spinal cord injury. Arch Phys Med
Rehabil 1990; 71: 197-200.
32. Ditunno JF. Formal CS. Current concepts: Chronic spinal
cord injury. N Engl J Med 1994; 330: 550-6.